American College of Cardiology

APRIL 29, 2024

The following are key points to remember from an American Heart Association scientific statement, which reviews the pathology, imaging, and current treatment options for the tricuspid valve (TV).

Tricuspid 58

Tricuspid Article 58

American College of Cardiology

MARCH 25, 2024

The following are key points to remember from a state-of-the-art review about the current status and perspectives on transcatheter treatment of the tricuspid valve (TV).

Tricuspid 53

Tricuspid Article 53

American College of Cardiology

AUGUST 31, 2024

trial was to assess the efficacy and safety of tricuspid transcatheter edge-to-edge repair (T-TEER) + guideline-directed medical therapy (GDMT) compared with GDMT alone among patients with symptomatic ≥ severe tricuspid regurgitation (TR). The goal of the TRI.Fr

Tricuspid 45

Tricuspid Article 45

American College of Cardiology

AUGUST 5, 2024

What are the 1-year clinical outcomes of subjects treated by tricuspid transcatheter edge-to-edge repair (T-TEER) with the TriClip system in a contemporary real-world setting?

Tricuspid 49

Tricuspid Outcomes Article 49

American College of Cardiology

OCTOBER 1, 2024

The tricuspid valve has historically received less attention compared to the valves on the left side of the heart. Tricuspid valve disease, however, is more common than previously thought, and if left untreated, it poses a significant risk of morbidity and mortality.

Tricuspid 45

Tricuspid Article 45

American College of Cardiology

FEBRUARY 26, 2024

What are survival rates after surgical or transcatheter intervention compared to conservative management based on tricuspid regurgitation (TR) clinical stage assessed using TRI-SCORE?

Tricuspid 45

Tricuspid Article 45

American College of Cardiology

OCTOBER 30, 2024

The goal of the TRISCEND II trial was to assess the safety and efficacy of Evoque transcatheter tricuspid valve replacement (TTVR) among patients with symptomatic severe tricuspid regurgitation (TR).

Tricuspid 45

Tricuspid Article 45

American College of Cardiology

OCTOBER 1, 2024

Our cover story this month, which outlines the issues surrounding tricuspid valve (TV) dysfunction, is worth a careful read. The story highlights the etiology, diagnosis and recent evolution of treatment strategies for TV dysfunction – medical, surgical and interventional.

Tricuspid 40

Tricuspid Article 40

Journal of Cardiovascular Electrophysiology

MARCH 7, 2024

Abstract Introduction Transvenous leads have been implicated in tricuspid valve (TV) dysfunction, but limited data are available regarding the effect of extracting leads across the TV on valve regurgitation. Methods We studied 321 patients who had echocardiographic data before and after lead extraction.

Tricuspid 40

Tricuspid Outcomes Article 40

European Journal of Heart Failure

NOVEMBER 8, 2023

Abstract Aim Functional or secondary tricuspid regurgitation (STR) is the most common phenotype of tricuspid regurgitation (TR) with atrial STR (ASTR) and ventricular STR (VSTR) being recently identified as two distinct entities. ASTR vs. VSTR) are lacking.

Tricuspid 40

Tricuspid Outcomes Atrial Fibrillation Pulmonary 40

Open Heart

FEBRUARY 7, 2024

Methods We searched for articles presenting the HR of two-dimensional RVfwLS in PH. Results Twenty articles totalling 2790 subjects were included. This systematic review and meta-analysis evaluated the prognostic value of RV free-wall longitudinal strain (RVfwLS), compared with other RV parameters in PH.

Pulmonary 52

Pulmonary Hypertension Tricuspid Article 52

American College of Cardiology

OCTOBER 27, 2024

What is the clinical impact of tricuspid regurgitation (TR) reduction with tricuspid transcatheter edge-to-edge repair (T-TEER)?

Tricuspid 60

Tricuspid Outcomes Article 60

European Journal of Heart Failure

MARCH 11, 2024

Abstract Aims The aim of this study was to assess the pathophysiological implications of severe tricuspid regurgitation (TR) in patients with heart failure with preserved ejection fraction (HFpEF) by using tricuspid transcatheter edge-to-edge repair (T-TEER) as a model of right ventricular (RV) volume overload relief.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Tricuspid Heart Failure Physiology 40

European Journal of Heart Failure

FEBRUARY 19, 2024

Tricuspid regurgitation (TR): frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. ESC-EORP, European Society of Cardiology-EURObservational Research Programme; TV, tricuspid valve.

Tricuspid 40

Tricuspid Heart Disease Bicuspid/Mitral Heart Valves 40

Frontiers in Cardiovascular Medicine

MARCH 19, 2024

Results A total of 36 articles were included in the systematic review analysis. 32% of CS patients had echocardiographic evidence of cardiac involvement, of which 79% involved tricuspid valve abnormalities. 32% of CS patients had echocardiographic evidence of cardiac involvement, of which 79% involved tricuspid valve abnormalities.

Heart Disease 59

Heart Disease Tricuspid Biomarkers Article 59

American College of Cardiology

JULY 2, 2024

Many patients with severe, symptomatic tricuspid regurgitation (TR) may also present with advanced heart failure with preserved ejection fraction (HFpEF), and treatments for each condition may impact the other condition.

Preserved Ejection Fraction 72

Preserved Ejection Fraction Tricuspid Heart Failure Article 72

American College of Cardiology

JULY 24, 2024

In this week’s View, Dr. Eagle looks at a study comparing three diuretic regimens in ambulatory congested heart failure (HF) patients (DEA-HF).

Tricuspid 58

Tricuspid Heart Failure Article 58

American College of Cardiology

AUGUST 31, 2024

Tricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation (TR) and improved quality of life after one year, based on findings from the Tri.fr trial presented at ESC Congress 2024 in London.

Quality of Life 49

Quality of Life Tricuspid Article 49

American College of Cardiology

FEBRUARY 28, 2024

In this week’s View, Dr. Eagle covers coronary calcium scores and how they predict ASCVD risk in the presence of left main disease and diabetes.

Diabetes 56

Diabetes Tricuspid Article 56

American College of Cardiology

MAY 20, 2024

A multidisciplinary care team (MDT) must balance the risks and benefits of transvenous lead extraction (TLE) vs. entrapping leads in patients with preexisting leads from cardiac implantable electronic device (CIED) being considered for orthotopic transcatheter tricuspid valve replacement (TTVR), which accounts for roughly 35% of the TTVR population, (..)

Tricuspid 60

Tricuspid Article 60

American College of Cardiology

NOVEMBER 26, 2024

Dr. Marwick discusses the SCOT-HEART trial, patient-echo reports augmented by AI, tricuspid valve regurgitation, and more. Marwick, MD, PhD, FACC, and Alison L. Bailey, MD FACC, discuss the Top Takeaways from 2024 in Cardiovascular (CV) Imaging.

Tricuspid 49

Tricuspid Article 49

American College of Cardiology

SEPTEMBER 11, 2024

What are the 3-year outcomes of tricuspid transcatheter edge-to-edge repair (T-TEER) with the TriClip implant for the treatment of severe symptomatic tricuspid regurgitation (TR)?

Tricuspid 45

Tricuspid Outcomes Article 45

American College of Cardiology

MARCH 27, 2024

In this week’s View, Dr. Eagle looks at sacubitril/valsartan in patients hospitalized with decompensated heart failure, then examines the prevalence and outcomes of patients with discordant high gradient aortic stenosis.

Heart Failure 58

Heart Failure Stenosis Aortic Tricuspid 58

American College of Cardiology

OCTOBER 21, 2024

Patients with moderate or severe tricuspid regurgitation (TR) prior to undergoing TAVR or mitral transcatheter edge-to-edge repair (TEER), when compared to patients with no or mild TR, were associated with worse health status and clinical outcomes, according to a study published in JACC: Cardiovascular Interventions.

TAVR 53

TAVR Bicuspid/Mitral Outcomes Tricuspid 53

All About Cardiovascular System and Disorders

FEBRUARY 14, 2024

In fact the Circulation article cited is on Complete Transposition of the Great Vessels. Tricuspid atresia – ECG Right atrial overload is manifest as tall P waves in lead II and left ventricular hypertrophy with strain pattern is seen in lateral leads with tall R waves, ST segment depression and T wave inversion.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease VSD 52

American College of Cardiology

DECEMBER 12, 2023

What is the impact of caval implantation of the TricValve system on quality of life (QOL) outcomes at 1 year among patients with severe symptomatic tricuspid regurgitation (TR)?

Quality of Life 53

Quality of Life Tricuspid Outcomes Article 53

American College of Cardiology

FEBRUARY 2, 2024

Food and Drug Administration (FDA) has approved the EVOQUE tricuspid valve replacement system for the treatment of tricuspid regurgitation (TR).

Tricuspid 40

Tricuspid Article 40

European Journal of Heart Failure

DECEMBER 7, 2023

Patients with HFpEF and biatrial myopathy had more atrial fibrillation, poorer left ventricular systolic and diastolic function, more severe pulmonary vascular disease, tricuspid regurgitation, ventricular interdependence and right ventricular dysfunction, and poorer cardiac output reserve with exercise. All rights reserved.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Heart Failure Exercise Atrial Fibrillation 40

Journal of Cardiovascular Electrophysiology

OCTOBER 21, 2024

HFpEF was diagnosed from a history of congestive HF and/or combined criteria of N-terminal pro-brain natriuretic peptide (NT-proBNP) concentration and transthoracic echocardiogram parameters, including average septal-lateral E/e' and tricuspid regurgitation peak velocity.

Preserved Ejection Fraction 40

Preserved Ejection Fraction Atrial Fibrillation Heart Failure Ablation 40

Journal of Cardiovascular Electrophysiology

DECEMBER 16, 2024

All patients demonstrated a significant decrease in LVEDD as well as a reduction in severity of mitral and tricuspid regurgitation during 1 year after LVAD implantation, reflecting left ventricular unloading through the LVAD.

Defibrillator 40

Defibrillator Arrhythmia Tricuspid Bicuspid/Mitral 40

Journal of Cardiovascular Pharmacology

MARCH 13, 2024

MCT group showed increase in RV hypertrophy, RV systolic area, RV systolic, mean pulmonary artery pressure (mPAP), and pulmonary vascular resistance (PVR), while exhibited a decrease in RV outflow tract AT/ET ratio, RV fractional shortening and tricuspid annular plane systolic excursion (TAPSE) compared to CTR (P<0.05).

Pulmonary 40

Pulmonary Hypertension Tricuspid Cardiac Function 40

The British Journal of Cardiology

FEBRUARY 20, 2024

Single-arm studies, conference presentations, animal studies, and studies that involved patients with tricuspid aortic morphology were excluded. Medical databases were queried to pool comparative studies of interest. Outcomes were pooled as risk ratios (RRs) with their 95% confidence intervals (CI) using the random effects model in R.

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

Dr. Smith's ECG Blog

JUNE 2, 2023

When I teach important syncope ECG patterns to my residents, I have always had to find case reports and review articles to show them the rare epsilon waves in the past. There is mild-moderate tricuspid valve regurgitation. They are rare and hard to find in normal practice in the ED. RVEF 34%, RV is mildly enlarged.

Tachycardia 83

Tachycardia Cardiomyopathy Electrocardiogram Article 83

Journal of Cardiovascular Electrophysiology

SEPTEMBER 26, 2024

Abstract Introduction Typical atrial flutter (AFL) is a macroreentrant tachycardia in which intracardiac conduction rotates counterclockwise around the tricuspid annulus. Typical AFL has specific electrocardiographic characteristics, including a negative sawtooth-like wave in the inferior lead and a positive F wave in lead V1.

Atrial Flutter 40

Atrial Flutter Tachycardia Tricuspid Electrocardiogram 40

Journal of Cardiovascular Electrophysiology

NOVEMBER 17, 2023

Abstract Introduction Cavo-tricuspid isthmus (CTI) dependent atrial flutter (AFL) is one of the most common atrial arrhythmias involving the right atrium (RA) for which radiofrequency catheter ablation has been widely used as a therapy of choice. However, there is limited data on the effect of this intervention on cardiac size and function.

Atrial Flutter 40

Atrial Flutter Ablation Heart Transplant Tricuspid 40

European Journal of Heart Failure

DECEMBER 13, 2023

6MWD, 6-min walk distance; CI, cardiac index; CPI, cardiac power index; LVEF, left ventricular ejection fraction; PA, pulmonary artery; PCW, pulmonary capillary wedge; RA, right atrial; TAPSE, tricuspid annular plane systolic excursion; TSAT, transferrin saturation; VO 2 , oxygen consumption.

Heart Failure 40

Heart Failure Heart Transplant Transplant Pulmonary 40

European Journal of Heart Failure

OCTOBER 30, 2023

Right-sided cardiac damage (rCD) was defined as pulmonary vasculature/tricuspid/right ventricular damage. The extent of cardiac damage was assessed by echocardiography according to an established staging classification. Hospitalization for heart failure (HHF) and/or death served as primary endpoint.

Stenosis 40

Stenosis Aortic Aortic valve Outcomes 40